|By Marketwired .||
|May 15, 2014 03:46 PM EDT||
NEW YORK, NY -- (Marketwired) -- 05/15/14 -- A recent European prostate cancer screening survey yielded surprising results to those leading the prostate cancer battle. Approximately 1,000 non-urologic specialists were asked about their prostate cancer screening practices and use of the prostate-specific antigen (PSA) test for patients aged 50 or older. In response to an in-person questionnaire, 90 percent of participants were not performing regular PSA tests or digital rectal exams on their elderly male patients.
Moreover, the study revealed that among those who were evaluating PSA, none was providing an informed decision-making consult about prostate cancer screening, nor did they themselves have any understanding of the strategy.
In April of 2013, the American Urologic Association (AUA) introduced the concept of informed or shared decision-making about the PSA test for men ages 55 to 69. Their goal was to curtail what they believed to be excessive screening and prostate cancer treatment. Though, experts like David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, fear the changes could impede early detection and treatment for men who need them most.
"It's very disheartening to learn that general care physicians and healthcare specialists are omitting the prostate cancer talk," said Dr. Samadi. "If patients aren't aware of their risk factors and the benefits of early detection, we simply perpetuate the dangers of late-stage prostate cancer diagnosis."
Last year, the AUA offered very specific and conservative guidelines for PSA testing of men within various age brackets. Among them was the recommendation that men aged 55 to 69 receive education about the pros and cons of PSA screening and actively participate in the decision of whether or not to be tested.
"The idea of empowering patients to take a more active role in their healthcare is important," said Dr. Samadi. "While this data is from Europe, it's possible that the AUA's recommendation to omit routine PSA testing may have an adverse effect on prostate cancer vigilance in the U.S. Early detection for men depends on awareness at all healthcare checkpoints."
The survey details were published in the March-April 2014 Urology Journal,
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2595095
David B. Samadi, M.D.
Chairman of Urology
Chief of Robotic Surgery at Lenox Hill Hospital
485 Madison Avenue
New York, NY 10022
Ask someone to architect an Internet of Things (IoT) solution and you are guaranteed to see a reference to the cloud. This would lead you to believe that IoT requires the cloud to exist. However, there are many IoT use cases where the cloud is not feasible or desirable. In his session at @ThingsExpo, Dave McCarthy, Director of Products at Bsquare Corporation, will discuss the strategies that exist to extend intelligence directly to IoT devices and sensors, freeing them from the constraints of ...
Oct. 1, 2016 11:45 AM EDT Reads: 2,791
Oct. 1, 2016 11:30 AM EDT Reads: 1,322
Oct. 1, 2016 11:15 AM EDT Reads: 871
Oct. 1, 2016 10:45 AM EDT Reads: 605
Oct. 1, 2016 10:30 AM EDT Reads: 710
Oct. 1, 2016 10:30 AM EDT Reads: 1,724
Oct. 1, 2016 10:00 AM EDT Reads: 3,198
Oct. 1, 2016 10:00 AM EDT Reads: 606
Oct. 1, 2016 10:00 AM EDT Reads: 4,672
Oct. 1, 2016 10:00 AM EDT Reads: 519
Oct. 1, 2016 10:00 AM EDT Reads: 3,321
Oct. 1, 2016 09:45 AM EDT Reads: 2,769
Oct. 1, 2016 09:45 AM EDT Reads: 835
Oct. 1, 2016 09:15 AM EDT Reads: 1,677